시장보고서
상품코드
1569464

녹내장 수술 기기 시장 규모, 점유율, 성장 분석 : 제품별, 수술 방법별, 최종 용도별, 지역별 - 산업 예측(2024-2031년)

Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product, By Surgery Method, By End-use, By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

녹내장 수술 기기 세계 시장 규모는 2022년 14억 달러로 평가되며, 2023년 14억 7,000만 달러에서 2031년에는 21억 2,000만 달러에 달할 것으로 예상되며, 예측 기간(2024-2031년) 동안 연평균 4.70%의 성장률을 보일 것으로 예상됩니다.

녹내장 수술 기기 시장은 특히 고령화 사회에서 녹내장 유병률의 증가로 인해 크게 성장할 것으로 예상됩니다. 이 안질환의 유병률이 증가함에 따라 효과적인 수술적 개입에 대한 수요도 증가하고 있으며, 성공률과 안전성 프로파일을 크게 개선한 수술 기술의 발전으로 뒷받침되고 있습니다. 최소침습 녹내장 수술(MIGS)로의 전환이 두드러지게 나타나고 있으며, 녹내장 배액 시스템 및 레이저 장비와 같은 장비는 합병증 발생률을 낮추고 환자 결과를 개선하여 인기를 얻고 있습니다. 또한, 관통형 마이크로바이패스 스텐트 및 맥락막상부 션트와 같은 기술을 특징으로 하는 최소침습적 수술의 추세는 백내장 수술과의 복합적 개입을 용이하게 하고 회복 기간을 단축시켜 시장에 혁명을 일으키고 있습니다. 녹내장 조기 발견과 조기 개입의 중요성에 대한 환자와 의료진의 인식이 높아지면서 시장 도입이 더욱 가속화되고 있습니다. 또한, 특히 북미와 유럽과 같은 신흥 시장에서는 유리한 상환 제도가 시장 확대를 촉진하고 있습니다. 더 나은 수술 결과를 촉진하는 환자 중심 치료의 중요성이 강조되면서 MIGS의 채택은 지속적으로 증가하고 있으며, 이는 성장의 매우 중요한 원동력이 되고 있습니다. 예측에 따르면, 미국 녹내장 수술 기기 시장은 향후 예측 기간 동안 건전한 CAGR을 유지할 것으로 예상되며, 이는 이 분야의 잠재력을 강조하고 있습니다.

목차

소개

  • 조사 목적
  • 정의
  • 시장 범위

조사 방법

  • 정보 조달
  • 2차 데이터 소스와 1차 데이터 소스
  • 시장 규모 예측
  • 시장 상정과 제한

주요 요약

  • 시장 개요 전망
  • 공급 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • Porters 분석

주요 시장 인사이트

  • 기술 분석
  • 밸류체인 분석
  • 시장 생태계
  • 사례 연구 분석
  • 규제 상황
  • 혁신 매트릭스
  • 주요 투자 분석
  • 주요 성공요인
  • 경쟁 정도

녹내장 수술 기기 시장 : 제품별

  • 시장 개요
  • 녹내장 배액 기기
  • 기존 수술용 디바이스
  • 다이아몬드 나이프
  • 레이저 시스템
  • 기타

녹내장 수술 기기 시장 : 수술 방법별

  • 시장 개요
  • 기존 녹내장 수술
  • 최소침습 녹내장 수술
  • 레이저 수술

녹내장 수술 기기 시장 : 최종 용도별

  • 시장 개요
  • 병원
  • 안과 클리닉
  • 기타

녹내장 수술 기기 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(MEA)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 상황

  • 상위 5개사의 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채용한 전략
  • 시장의 최근 활동
  • 주요 기업의 시장 점유율(2023년)

주요 기업 개요

  • Alcon, Inc.(Switzerland)
  • Glaukos Corporation(US)
  • Johnson & Johnson Vision(US)
  • ASICO, LLC(US)
  • Carl Zeiss Meditec AG(Germany)
  • Ziemer Ophthalmic Systems AG(Switzerland)
  • Iridex Corporation(US)
  • Altomed(UK)
  • New World Medical, Inc.(US)
  • Ellex Medical Lasers Ltd.(Australia)
  • Topcon Corporation(Japan)
  • BVI Medical, Inc.(US)
  • MicroSurgical Technology(MST)(US)
  • Molteno Ophthalmic Ltd.(New Zealand)
  • OptoMedica Corporation(US)
  • iStar Medical SA(Belgium)
  • NeoMedix Corporation(US)
  • Sight Sciences, Inc.(US)
  • Aquesys, Inc.(US)
  • IOP Ophthalmics(US)
  • Katena Products, Inc.(US)
ksm 24.10.23

Global Glaucoma Surgery Devices Market size was valued at USD 1.40 billion in 2022 and is poised to grow from USD 1.47 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 4.70% during the forecast period (2024-2031).

The glaucoma surgery devices market is on the brink of significant growth, primarily fueled by the escalating global incidence of glaucoma, particularly among the aging population. As the prevalence of this eye condition rises, the demand for effective surgical interventions is also increasing, supported by advancements in surgical techniques that have markedly improved success rates and safety profiles. A notable shift toward minimally invasive glaucoma surgery (MIGS) has been observed, with devices like glaucoma drainage systems and laser equipment gaining popularity for their reduced complication rates and enhanced patient outcomes. The trend toward less invasive procedures, characterized by techniques such as trabecular micro-bypass stents and suprachoroidal shunts, is revolutionizing the market, allowing for shorter recovery periods while facilitating combined interventions with cataract surgeries. Increased awareness among patients and healthcare providers about the critical importance of early glaucoma detection and intervention further drives market adoption. Additionally, favorable reimbursement frameworks, especially in developed regions like North America and Europe, bolster market expansion. With a heightened emphasis on patient-centered care that promotes better surgical outcomes, the adoption of MIGS is set to continue its upward trajectory, making it a pivotal driver of growth. According to projections, the US glaucoma surgery devices market is anticipated to sustain a healthy compound annual growth rate (CAGR) in the upcoming forecast period, underscoring the promising future of this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global glaucoma surgery devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global glaucoma surgery devices Market Segmental Analysis

Global Glaucoma Surgery Devices Market is segmented by Product, Surgery Method, End-use, and region. Based on Product, the market is segmented into Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, and Others. Based on Surgery Method, the market is segmented into Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery. Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is significantly driven by the aging population and a rise in lifestyle-related factors, including prolonged screen time and an increase in diabetes prevalence, which contribute to a higher incidence of glaucoma. This escalating prevalence necessitates effective surgical interventions, thus intensifying the demand for advanced glaucoma surgery devices. Additionally, heightened awareness among healthcare providers and patients regarding the critical importance of early detection and timely treatment of glaucoma amplifies this market growth. As the healthcare landscape continues to evolve, the pressing need for innovative surgical solutions to combat glaucoma will further bolster the market's expansion.

Restraints in the global glaucoma surgery devices Market

The global glaucoma surgery devices market faces a significant restraint due to the high cost associated with surgical procedures. Factors including the necessity for advanced, specialized equipment, the requirement for highly skilled healthcare providers, and comprehensive post-operative care contribute to increased expenses. Additionally, the cost of the devices themselves adds to the financial burden, making glaucoma surgeries unaffordable for many patients, particularly in developing regions or among those lacking sufficient insurance coverage. This economic barrier not only restricts patient access to essential surgical interventions but also hampers the overall growth potential of the glaucoma surgery devices market.

Market Trends of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is witnessing a significant trend towards combination therapies, which integrate various treatment modalities to optimize intraocular pressure (IOP) management. This approach enhances therapeutic outcomes by leveraging the synergistic effects of medications, laser treatments, and surgical techniques. The emergence of advanced glaucoma devices that incorporate drug-delivery systems, such as sustained-release implants, exemplifies this trend, allowing for targeted and controlled drug administration alongside surgical interventions. As healthcare providers increasingly adopt these innovative solutions, the market is positioned for robust growth, driven by the demand for more effective and personalized glaucoma treatment options.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Glaucoma Surgery Devices Market by Product

  • Market Overview
  • Glaucoma Drainage Device
    • Valves
    • Glaucoma Drainage Implant
    • Glaucoma Tube Shunts
    • Stents
  • Traditional Surgery Devices
    • Scalpel
    • Forceps
    • Ophthalmic Scissors
    • Punch
    • Sutures
    • Surgical Drapes
    • Microcatheter
    • Others
  • Diamond Knives
  • Laser Systems
  • Others

Glaucoma Surgery Devices Market by Surgery Method

  • Market Overview
  • Traditional Glaucoma Surgery
    • Trabeculectomy
    • Tube Shunt Surgery
  • Minimal Invasive Glaucoma Surgery
    • Trabecular Meshwork Bypass
    • Suprachoroidal Space Implants
    • Subconjunctival Space Implants
    • Schlemm's Canal Implants
    • Gonioscopy-assisted Transluminal Trabeculectomy
    • Endocyclophotocoagulation
  • Laser Surgery
    • Trabeculoplasty
    • Iridotomy
    • Cyclophotocoagulation

Glaucoma Surgery Devices Market by End-use

  • Market Overview
  • Hospitals
  • Ophthalmic Clinics
  • Others

Glaucoma Surgery Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Alcon, Inc. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Glaukos Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Vision (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ASICO, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss Meditec AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ziemer Ophthalmic Systems AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Iridex Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Altomed (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New World Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ellex Medical Lasers Ltd. (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Topcon Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BVI Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroSurgical Technology (MST) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molteno Ophthalmic Ltd. (New Zealand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OptoMedica Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iStar Medical SA (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeoMedix Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sight Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aquesys, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IOP Ophthalmics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Katena Products, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제